A world's first vaccine for deadly ovarian cancer currently being developed in the UK could eradicate the deadly disease, ...

Being diagnosed with breast cancer is overwhelming. But, during the monthlong National Breast Cancer Awareness campaign which ...

Discover which hepatocytes are suitable for various study types and learn why hepatocytes are critical for ADME/DMPK ...

Arrowhead's plozasiran shows promising Phase 3 data for FCS, with potential blockbuster status, but faces competition. Learn ...

A new study from Stanford Medicine suggests that glucose plays a surprising role in the aging brain's ability to produce new ...

Chinese biotech firms WuXi AppTec and WuXi Biologics are exploring the sale of certain operations in response to potential ...

Revvity, Inc., announced today the launch of the in-vitro diagnostic EURORealTime™ APOE assay in European countries that accept the CE mark, which will enable accurate genotyping of the APOE gene.

In addition, a 2024 study revealed that stuttering may be triggered by disruption to a network of neurons in the brain that ...

Quell’s proprietary platform has been developed to generate engineered CAR-Treg cell therapies that can be directed to ...

A new study has uncovered a startling revelation: rare genetic disorders caused by repetitive DNA sequences may be up to ...

The sequencing of the human genome at the turn of the 21st century was heralded as a monumental scientific achievement ...